Redhill Biopharma
RDHL
$0.42
Share price
-0.88%
Change (1 day)
-83.08%
Change (1 year)
Categories
Earnings for Redhill Biopharma (RDHL)
Earnings in 2023 (TTM): $11.57 M
According to Redhill Biopharma's latest financial reports the company's current earnings (TTM) are $11.57 M. In 2022 the company made an earning of -$71.67 M an increase over its 2021 earnings that were of -$97.75 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Redhill Biopharma from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $11.57 M | -116.15% |
| 2022 | -$71.67 M | -26.68% |
| 2021 | -$97.75 M | 28.32% |
| 2020 | -$76.18 M | 80.06% |
| 2019 | -$42.31 M | 8.97% |
| 2018 | -$38.82 M | -14.76% |
| 2017 | -$45.55 M | 55.07% |
| 2016 | -$29.37 M | 39.26% |
| 2015 | -$21.09 M | 96.9% |
| 2014 | -$10.72 M | 0.78% |
| 2013 | -$10.63 M | 16.93% |
| 2012 | -$9.09 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $8.39 B | 72,448.74% | 🇫🇷 France |
 Merck MRK | $3.03 B | 26,127.10% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | 65,014.24% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 3,399.83% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $43.72 M | 277.87% | 🇮🇱 Israel |